After operating as one organization since 2024, we’d like to officially introduce the next era of PCM Trials, EmVenio Research and Clinical Trial Service: EmVenio Clinical Research.
Medical breakthroughs don’t happen by chance. It takes time, people, commitment and determination to go further than before. Together, we share a mission of reaching patients where they are – in their homes, their communities and where they gather – and collaborating with partners to address their specific challenges, no matter what those might be. With research capabilities extending over 80 countries, we continually enroll populations others miss, creating a more complete picture for scientific advancement.
By forging lasting relationships with patients and partners, we better understand their unique needs, constraints and goals. By bringing the humanity behind research data to the forefront, we commit to maintaining industry-leading retention rates while delivering the insights our partners need.
About this email: You are receiving this message as part of your complimentary newsletter subscription to BioPharma Dive. If you no longer wish to receive the daily newsletter, you can switch to a weekly subscription or unsubscribe. See our full privacy policy. BioPharma Dive is a product of TechTarget, Inc. and its subsidiaries, 275 Grove St. Newton, MA, 02466